Search research articles
Contact Us
Filters
Showing results (281-290 of 455) with videos related to
Page
of 46
Sort By:
Journal of Medicinal Chemistry
|
December 20, 2015
2-Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy
Ashraf Saeed, Grant M Vaught, Kostas Gavardinas, et al.
Circulation
|
November 10, 2025
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: a Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
Marianna Fontana, Pablo Garcia-Pavia, Martha Grogan, et al.
European Journal of Heart Failure
|
March 2, 2026
Impact of acoramidis on clinical stability in transthyretin amyloid cardiomyopathy: Observations from ATTRibute-CM
Francesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia, et al.
Kidney International Reports
|
September 21, 2020
CKD Care and Research in Guatemala: Overview and Meeting Report
Pablo Garcia, Carlos Mendoza, Joaquin Barnoya, et al.
The New England Journal of Medicine
|
May 22, 2023
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid
Pablo Garcia-Pavia, Fabian Aus dem Siepen, Erwan Donal, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
December 15, 2018
The Impact of Diabetes on Outcomes After Acute Ischemic Stroke: A Prospective Observational Study
Naveed Akhtar, Saadat Kamran, Rajvir Singh, et al.
Journal of Clinical Medicine
|
December 11, 2025
Long-Term Biochemical and Cardiovascular Profiles 3-6 Years After Preeclampsia: Impact of Angiogenic Imbalance During Pregnancy
Noah Costa, Judit Platero, Pablo Garcia-Manau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma
Khuda D Khan, Christos Emmanouilides, Don M Benson, et al.
European Heart Journal
|
March 23, 2017
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
Esther González-López, Christian Gagliardi, Fernando Dominguez, et al.
JACC. Heart Failure
|
January 4, 2024
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort
Florian Rader, Artur Oręziak, Lubna Choudhury, et al.
Page
of 46
Search research articles
Search
Showing results (281-290 of 455) with videos related to
Sort By:
Page
of 46
Journal of Medicinal Chemistry
|
December 20, 2015
2-Chloro-4-[[(1R,2R)-2-hydroxy-2-methyl-cyclopentyl]amino]-3-methyl-benzonitrile: A Transdermal Selective Androgen Receptor Modulator (SARM) for Muscle Atrophy
Ashraf Saeed, Grant M Vaught, Kostas Gavardinas, et al.
Circulation
|
November 10, 2025
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: a Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
Marianna Fontana, Pablo Garcia-Pavia, Martha Grogan, et al.
European Journal of Heart Failure
|
March 2, 2026
Impact of acoramidis on clinical stability in transthyretin amyloid cardiomyopathy: Observations from ATTRibute-CM
Francesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia, et al.
Kidney International Reports
|
September 21, 2020
CKD Care and Research in Guatemala: Overview and Meeting Report
Pablo Garcia, Carlos Mendoza, Joaquin Barnoya, et al.
The New England Journal of Medicine
|
May 22, 2023
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid
Pablo Garcia-Pavia, Fabian Aus dem Siepen, Erwan Donal, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
|
December 15, 2018
The Impact of Diabetes on Outcomes After Acute Ischemic Stroke: A Prospective Observational Study
Naveed Akhtar, Saadat Kamran, Rajvir Singh, et al.
Journal of Clinical Medicine
|
December 11, 2025
Long-Term Biochemical and Cardiovascular Profiles 3-6 Years After Preeclampsia: Impact of Angiogenic Imbalance During Pregnancy
Noah Costa, Judit Platero, Pablo Garcia-Manau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma
Khuda D Khan, Christos Emmanouilides, Don M Benson, et al.
European Heart Journal
|
March 23, 2017
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths
Esther González-López, Christian Gagliardi, Fernando Dominguez, et al.
JACC. Heart Failure
|
January 4, 2024
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort
Florian Rader, Artur Oręziak, Lubna Choudhury, et al.
Page
of 46